Neurological deterioration in patients with urea cycle disorders under valproate therapy--a cause for concern.
Sewell
A C
AC
Böhles
H J
HJ
Herwig
J
J
Demirkol
M
M
D000293:Adolescent; D000592:Amino Acid Metabolism, Inborn Errors / Q000150:complications* / Q000201:enzymology; D000641:Ammonia / Q000097:blood*; D001120:Arginine / Q000097:blood*; D002648:Child; D004827:Epilepsy / Q000188:drug therapy* / Q000201:enzymology; D005260:Female; D006801:Humans; D020162:Hyperargininemia; D009460:Neurologic Examination / Q000187:drug effects*; D012307:Risk Factors; D014635:Valproic Acid / Q000008:administration & dosage / Q000009:adverse effects*
D014635:Valproic Acid; D000641:Ammonia; D001120:Arginine